We are live on ! Find out more
PIII icon

P3 Health Partners
PIII

46 hedge funds and large institutions have $12.4M invested in P3 Health Partners in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 16 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.08% less ownership

Funds ownership: 0.47% → 0.4% (-0.08%)

23% less funds holding

Funds holding: 60 → 46 (-14)

28% less capital invested

Capital invested by funds: $17.2M → $12.4M (-$4.83M)

65% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 20

69% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 16

Holders
46
Holders Change
-14
Holders Change %
-23.33%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
16
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$993K
2
Corient Private Wealth
Corient Private Wealth
Florida
+$905K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$289K
4
AWC
Abundance Wealth Counselors
Pennsylvania
+$210K
5
Renaissance Technologies
Renaissance Technologies
New York
+$195K

Top Sellers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
-$2.85M
2
AC
Armistice Capital
New York
-$655K
3
Goldman Sachs
Goldman Sachs
New York
-$244K
4
Jane Street
Jane Street
New York
-$148K
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$132K
Name Holding Trade Value Shares
Change 		Change in
Stake
SW
26
SlateStone Wealth
Florida
$11K – – –
Jane Street
27
Jane Street
New York
$9.81K -$148K -5,662 -92%
HighTower Advisors
28
HighTower Advisors
Illinois
$9K – – –
MIP
29
Marietta Investment Partners
Wisconsin
$5.79K – – –
MFIM
30
Mesirow Financial Investment Management
Illinois
$5.79K – – –
TRCT
31
Tower Research Capital (TRC)
New York
$4.91K -$6.18K -236 -48%
PAS
32
Point72 Asia (Singapore)
Singapore
$4.64K +$6.29K +240 New
Goldman Sachs
33
Goldman Sachs
New York
$4.6K -$244K -9,296 -98%
CFM
34
Catalyst Funds Management
Australia
$4.02K – – –
ISL
35
Ingalls & Snyder LLC
New York
$4K – – –
WAM
36
Warberg Asset Management
Illinois
$3.86K +$5.24K +200 New
Bank of America
37
Bank of America
North Carolina
$913 -$27.9K -1,064 -96%
JP Morgan Chase
38
JP Morgan Chase
New York
$878 -$29.2K -1,116 -96%
CSS
39
Cubist Systematic Strategies
Connecticut
$682 +$917 +35 New
TCM
40
Tuttle Capital Management
Connecticut
$490 – – –
Fidelity Investments
41
Fidelity Investments
Massachusetts
$440 -$10.8K -411 -95%
WAM
42
Wolverine Asset Management
Illinois
$225 – – –
Citigroup
43
Citigroup
New York
$132 -$2.85K -109 -94%
AAP
44
Arax Advisory Partners
Colorado
$100 – – –
UBS Group
45
UBS Group
Switzerland
$87 -$14.6K -558 -99%
CFGS
46
Concourse Financial Group Securities
Alabama
$77 – – –
Ameriprise
47
Ameriprise
Minnesota
– -$2.85M -126,562 Closed
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
– -$117K -5,179 Closed
GCP
49
GSA Capital Partners
United Kingdom
– -$91K -4,029 Closed
YIH
50
Y-Intercept (HK)
Hong Kong
– -$89K -3,952 Closed
1
2
3

PIII Hedge Fund Activity: Q3 2024 in Review

46 of the 6,969 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q3 2024, worth a combined $12.4M — down 28% from $17.2M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of PIII and 7 opened new positions — a net loss of 13 holders — while 16 trimmed existing stakes and 5 added.

The largest buyer was Morgan Stanley, adding an estimated $993K. The largest seller was Ameriprise, exiting entirely with an estimated $2.85M sold.

  • 46 institutional investors held P3 Health Partners (PIII) as of Q3 2024, down from 60 in Q2 2024.
  • Funds reported $12.4M of P3 Health Partners stock for Q3 2024, down 28% quarter-over-quarter.
  • 7 funds opened new P3 Health Partners positions in Q3 2024 and 20 closed out, a net change of -13 holders.
  • The largest P3 Health Partners buyer in Q3 2024 was Morgan Stanley, an estimated $993K added.
  • The largest P3 Health Partners seller in Q3 2024 was Ameriprise, an estimated $2.85M sold.

Based on aggregated 13F filings for Q3 2024.